Treatment and management of celiac disease;Therapie und management der zöliakie/einheimischen sprue

Zeitschrift fur Gastroenterologie

Volumn 44, Issue 11, 2006, Pages 1167-1175

  Holtmeier, Wolfgang ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Celiac disease; Coeliac disease; Complications; Management

Indexed keywords

AZATHIOPRINE; BUDESONIDE; CYCLOSPORIN; GLUTEN; INFLIXIMAB; TSUKUBAENOLIDE;

CANCER RISK; CELIAC DISEASE; COLON CROHN DISEASE; DIET THERAPY; DIGESTIVE SYSTEM CANCER; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOD CONTAMINATION; FOOD INTAKE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALABSORPTION; NONHODGKIN LYMPHOMA; PANCREAS INSUFFICIENCY; PATIENT CARE; REVIEW; T CELL LYMPHOMA;

CELIAC DISEASE; DIET, PROTEIN-RESTRICTED; GLUTEN; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES;

EID: 33845383077     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-927125     Document Type: Review

References (132)

1. Holtmeier W. Diagnosis of celiac disease. Z Gastroenterol 2005; 43: 1243-1252
2. Holtmeier W, Henker J, Riecken EO et al. Verlaufsformen und Definitionen der Zöliakie - Stellungnahme einer Expertengruppe der Deutschen Zöliakie-Gesellschaft. Z Gastroenterol 2005; 43: 751-754
3. Holtmeier W, Caspary WF. Celiac disease. Orphanet Journal of Rare Diseases 2006; I: 3; http://www.ojrd.com/content/1/1/3
4. Abdulkarim AS, Burgart LJ, See jet al. Etiology of nonresponsive celiac disease: Results of a systematic approach. Am J Gastroenterol 2002; 97: 2016-2021
5. Kupper C. Dietary guidelines and implementation for celiac disease. Gastroenterology 2005; 128: S121-S127
6. Collin P, Thorell L, Kaukinen K et al. The safe threshold for gluten contamination in gluten-free products. Can trace amounts be accepted in the treatment of coeliac disease? Aliment Pharmacol Ther 2004; 19: 1277-1283
7. Hischenhuber C, Crevel R, Jarry B et al. Review article: safe amounts of gluten for patients with wheat allergy or coeliac disease. Aliment Pharmacol Ther 2006; 23: 559-575
8. Case S. The gluten-free diet: How to provide effective education and resources. Gastroenterology 2005; 128: S128-S134
9. Stern M, Ciclitira PJ, van Eckert R et al. Analysis and clinical effects of gluten in coeliac disease. Eur J Gastroenterol Hepatol 2001; 13: 741-747
10. Weinstein WM. Latent celiac sprue. Gastroenterology 1974; 66: 489-493
11. Ciclitira PJ, Ellis HJ, Lundin KE. Gluten-free diet - what is toxic? Best Pract Res Clin Gastroenterol 2005; 19: 359-371
12. van de Wal Y, Kooy YM, van Veelen P et al. Glutenin is involved in the gluten-driven mucosal T cell response. Eur J Immunol 1999; 29: 3133-3139
13. Vader W, Kooy Y, van Veelen P et al. The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology 2002; 122: 1729-1737
14. Molberg O, Solheim FN, Jensen T et al. Intestinal T-cell responses to high-molecular-weight glutenins in celiac disease. Gastroenterology 2003; 125: 337-344
15. Mothes T, Stern M. How gluten-free is gluten-free, and what does this mean to coeliac patients? Eur J Gastroenterol Hepatol 2003; 15: 461-463
16. Catassi C, Fabiani E, Mandolesi A et al. The Italian study on gluten microchallenge: preliminary results. In: Stern M (Hrsg). Proceedings of the 19th meeting; working group on prolamin analysis and toxicity. Zwickau: Verlag wissenschaftliche Scripten, 2005: 109-114
17. Valdes I, Garcia E, Llorente M et al. Innovative approach to low-level gluten determination in foods using a novel sandwich enzyme-linked immunosorbent assay protocol. Eur J Gastroenterol Hepatol 2003; 15: 465-474
18. Stern M. A major step towards a practical and meaningful gluten analysis. Eur J Gastroenterol Hepatol 2005; 17: 523-524
19. Collin P, Maki M, Kaukinen K. It is the compliance, not milligrams of gluten, that is essential in the treatment of celiac disease. Nutr Rev 2004; 62: 490
20. Kasarda DD, Okita TW, Bernardin JE et al. Nucleic acid (cDNA) and amino acid sequences of a-type gliadins from wheat (Triticum aestivum L.). Proc Natl Acad Sci USA 1984; 81: 4712
21. Hardman CM, Garioch JJ, Leonard JN et al. Absence of toxicity of oats in patients with dermatitis herpetiformis. N Engl J Med 1997; 337: 1884-1887
22. Hogberg L, Laurin P, Falth-Magnusson K et al. Oats to children with newly diagnosed coeliac disease: a randomised double blind study. Gut 2004; 53: 649-654
23. Janatuinen EK, Kemppainen TA, Pikkarainen PH et al. Lack of cellular and humoral immunological responses to oats in adults with coeliac disease. Gut 2000; 46: 327-331
24. Janatuinen EK, Kemppainen TA, Julkunen RJK et al. No harm from five year ingestion of oats in coeliac disease. Gut 2002; 50: 332-335
25. Vader LW, de Ru A, WY et al. Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. J Exp Med 2002; 195: 643-649
26. Kilmartin C, Lynch S, Abuzakouk M et al. Avenin fails to induce a Th1 response in coeliac tissue following in vitro culture. Gut 2003; 52: 47-52
27. Peraaho M, Kaukinen K, Mustalahti K et al. Effect of an oats-containing gluten-free diet on symptoms and quality of life in coeliac disease. A randomized study. Scand J Gastroenterol 2004; 39: 27-31
28. Lundin KE, Nilsen EM, Scott HC et al. Oats induced villous atrophy in coeliac disease. Gut 2003; 52: 1649-1652
29. Peraaho M, Collin P, Kaukinen K et al. Oats can diversify a gluten-free diet in celiac disease and dermatitis herpetiformis. J Am Diet Assoc 2004; 104: 1148-1150
30. Dickey W, Hughes DF. Histology of the terminal ileum in coeliac disease. Scand J Gastroenterol 2004; 39: 665-667
31. Dickey W. Low serum vitamin B12 is common in coeliac disease and is not due to autoimmune gastritis. Eur J Gastroenterol Hepatol 2002; 14: 425-427
32. Vahedi K, Mascart F, Mary JY et al. Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease. Am J Gastroenterol 2003; 98: 1079-1087
33. Walker-Smith JA, Guandalini S, Schmitz J et al. Revised criteria for diagnosis of coeliac disease. Arch Dis Child 1990; 65: 909-911
34. Hill ID, Dirks MH, Liptak GS et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2005; 40: 1-19
35. National Institutes of Health Consensus Development Conference Statement on Celiac Disease, 28 - 30.6.2004. Gastroenterology 2005; 128: S1-S9
36. Kaukinen K, Sulkanen S, Maki M et al. IgA-class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in coeliac disease. Eur J Gastroenterol Hepatol 2002; 14: 311-315
37. Pietzak MM. Follow-up of patients with celiac disease: Achieving compliance with treatment. Gastroenterology 2005; 128: S135-S141
38. Bazzigaluppi E, Roggero P, Parma B et al. Antibodies to recombinant human tissue-transglutaminase in coeliac disease: Diagnostic effectiveness and decline pattern after gluten-free diet. Dig Liver Dis 2006; 38: 98-102
39. Fabiani E, Carassi C. The serum IgA class anti-tissue transglutaminase antibodies in the diagnosis and follow up of coeliac disease. Results of an international multi-centre study. International Working Group on Eu-tTG. Eur J Gastroenterol Hepatol 2001; 13: 659-665
40. Wanab PJ, Meijer JWR, Mulder CJJ. Histologic follow-up of people with celiac disease on a gluten- free diet - Slow and incomplete recovery. Am J Clin Pathol 2002; 118: 459-463
41. Collin P, Maki M, Kaukinen K. Complete small intestine mucosal recovery is obtainable in the treatment of celiac disease. Gastrointest Endose 2004; 59: 158-159
42. Lee SK, Lo W, Memeo L et al. Duodenal histology in patients with celiac disease after treatment with a gluten-free diet. Gastrointes Endoscopy 2003; 57: 187-191
43. Tursi A, Brandimarte G, Giorgetti GM. Lack of usefulness of anti-transglutaminase antibodies in assessing histologic recovery after gluten-free diet in celiac disease. J Clin Gastroenterol 2003; 37: 387-391
44. Schmitz J. Is celiac disease a lifelong disorder? Clin Invest Med 1996; 19: 352-356
45. Walker-Smith J. Transient gluten intolerance. Arch Dis Child 1970; 45: 523-526
46. Meuli R, Pichler WJ, Gaze H et al Genetic difference in HLA-DR phenotypes between coeliac disease and transitory gluten intolerance. Arch Dis Child 1995; 72: 29-32
47. Limbach A, Hoepffner W, Tannapfel A et al. Long-term study of patients with coeliac disease in childhood and adolescence: latent and transient coeliac disease. Klin Padiatr 2003; 215: 76-81
48. Fasano A. European and North American populations should be screened for coeliac disease. Gut 2003; 52: 168-169
49. Kumar PJ. European and North American populations should be screened for coeliac disease. Gut 2003; 52: 170-171
50. Lebwohl B, Green PH. Screening for celiac disease. N Engl J Med 2003; 349: 1673-1674
51. Collin P. Should adults be screened for celiac disease? What are the benefits and harms of screening? Gastroenterology 2005; 128: S104-S108
52. Holmes GK, Prior P, Lane MR et al. Malignancy in coeliac disease - effect of a gluten free diet. Gut 1989; 30: 333-338
53. Mearin ML, Catassi C, Brousse N et al. European multi-centre study on coeliac disease and non-Hodgkin lymphoma. Eur J Gastroenterol Hepatol 2006; 18: 187-194
54. Ventura A, Magazzu G, Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology 1999; 117: 297-303
55. Sategna GC, Solerio E, Scaglione N et al. Duration of gluten exposure in adult coeliac disease does not correlate with the risk for autoimmune disorders. Gut 2001; 49: 502-505
56. Viljamaa M, Kaukinen K, Huhtala H et al. Coeliac disease, autoimmune diseases and gluten exposure. Scand J Gastroenterol 2005; 40: 437-443
57. Mustalahti K, Lohiniemi S, Collin P et al. Gluten-free diet and quality of life in patients with screen-detected celiac disease. Eff Clin Pract 2002; 5: 105-113
58. Johnston SD, Rodgers C, Watson RG. Quality of life in screen-detected and typical coeliac disease and the effect of excluding dietary gluten. Eur J Gastroenterol Hepatol 2004; 16: 1281-1286
59. Fabiani E, Taccari LM, Ratsch IM et al. Compliance with gluten-free diet in adolescents with screening-detected celiac disease: a 5-year follow-up study. J Pediatr 2000; 136: 841-843
60. Mayer M, Greco L, Troncone R et al. Compliance of adolescents with coeliac disease with a gluten free diet. Gut 1991; 32: 881-885
61. Kumar PJ, Walker-Smith J, Milla P et al. The teenage coeliac: follow up study of 102 patients. Arch Dis Child 1988; 63: 916-920
62. Bardella MT, Molteni N, Prampolini L et al. Need for follow up in coeliac disease. Arch Dis Child 1994; 70: 211-213
63. Corrao G, Corazza GR, Bagnardi V et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 2001; 358: 356-361
64. Peters U, Askling J, Gridley G et al. Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med 2003; 163: 1566-1572
65. Kemppainen T, Kroger H, Janatuinen E et al. Osteoporosis in adult patients with celiac disease. Bone 1999; 24: 249-255
66. Corazza GR, Di Sario A, Cecchetti L et al. Bone mass and metabolism in patients with celiac disease. Gastroenterology 1995; 109: 122-128
67. Corazza GR, Di Sario A, Cecchetti L et al. Influence of pattern of clinical presentation and of gluten-free diet on bone mass and metabolism in adult coeliac disease. Bone 1996; 18: 525-530
68. Thomason K, West J, Logan RF et al. Fracture experience of patients with coeliac disease: a population based survey. Gut 2003; 52: 518-522
69. West J, Logan RF, Card TR et al. Fracture risk in people with celiac disease: a population-based cohort study. Gastroenterology 2003; 125: 429-436
70. Bernstein CN, Leslie WD, Leboff MS. AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology 2003; 124: 795-841
71. Collin P, Vilska S, Heinonen PK et al. Infertility and coeliac disease. Gut 1996; 39: 382-384
72. Sher KS, Jayanthi V, Probert CS et al. Infertility, obstetric and gynaecological problems in coeliac sprue. Dig Dis 1994; 12: 186-190
73. Sher KS, Mayberry JF. Female fertility, obstetric and gynaecological history in coeliac disease. A case control study. Digestion 1994; 55: 243-246
74. Tata LJ, Card TR, Logan RF et al. Fertility and pregnancy-related events in women with celiac disease: a population-based cohort study. Gastroenterology 2005; 128: 849-855
75. Farthing MJ, Rees LH, Edwards CR et al. Male gonadal function in coeliac disease: 2. Sex hormones. Gut 1983; 24: 127-135
76. Farthing MJ, Rees LH, Dawson AM. Male gonadal function in coeliac disease: III. Pituitary regulation. Clin Endocrinol (Oxf) 1983; 19: 661-671
77. Hozyasz KK. Coeliac disease and birth defects in offspring. Gut 2001; 49: 738
78. Ludvigsson JF, Montgomery SM, Ekbom A. Celiac disease and risk of adverse fetal outcome: a population-based cohort study. Gastroenterology 2005; 129: 454-463
79. Shetner E, Peleg R, Levy A. Pregnancy outcome of patients with known celiac disease. Eur J Obstet Gynecol Reprod Biol 2005; article ahead of print: http://dx.doi.org/10.1016/j.ejogrb.2005.10.023
80. Ryan BM, Kelleher D. Refractory celiac disease. Gastroenterology 2000; 119: 243-251
81. Trier JS, Falchuk ZM, Carey MC et al. Celiac sprue and refractory sprue. Gastroenterology 1978; 75: 307
82. Cellier C, Delabesse E, Helmer C et al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. Lancet 2000; 356: 203-208
83. Catassi C, Bearzi I, Holmes GKT. Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology 2005; 128: S79-S86
84. Biagi F, Corazza GR. Defining gluten refractory enteropathy. Eur J Gastroenterol Hepatol 2001; 13: 561-565
85. Verkarre V, Asnafi V, Lecomte T et al. Refractory coeliac sprue is a diffuse gastrointestinal disease. Gut 2003; 52: 205-211
86. Daum S, Cellier C, Mulder CJ. Refractory coeliac disease. Best Pract Res Clin Gastroenterol 2005; 19: 413-424
87. Goldstein NS. Non-gluten sensitivity-related small bowel villous flattening with increased intraepithelial lymphocytes: not all that flattens is celiac sprue. Am J Clin Pathol 2004; 121: 546-550
88. Goerres MS, Meijer JW, Wahab PJ et al. Azathioprine and prednisone combination therapy in refractory coeliac disease. Aliment Pharmacol Ther 2003; 18: 487-494
89. Corazza GR, Biagi F, Volta U et al. Autoimmune enteropathy and villous atrophy in adults. Lancet 1997; 350: 106-109
90. Rolny P, Sigurjonsdottir HA, Remotti H et al. Role of immunosuppressive therapy in refractory sprue-like disease. Am J Gastroenterol 1999; 94: 219-225
91. Turner SM, Moorghen M, Probert CS. Refractory coeliac disease: remission with infliximab and immunomodulators. Eur J Gastroenterol Hepatol 2005; 17: 667-669
92. Daum S, Ipczynski R, Heine B et al. Therapy with budesonide in patients with refractory sprue. Digestion 2006; 73: 60-68
93. Vaidya A, Bolanos J, Berkelhammer C. Azathioprine in refractory sprue. Am J Gastroenterol 1999; 94: 1967-1969
94. Olaussen RW, Lovik A, Tollefsen S et al. Effect of elemental diet on mucosal immunopathology and clinical symptoms in type 1 refractory celiac disease. Clin Gastroenterol Hepatol 2005; 3: 875-885
95. Daum S, Weiss D, Hummel M et al. Frequency of clonal intraepithelial T lymphocyte proliferations in enteropathy-type intestinal T cell lymphoma, coeliac disease, and refractory sprue. Gut 2001; 49: 804-812
96. Daum S, Hummel M, Weiss D et al. Refractory sprue syndrome with clonal intraepithelial lymphocytes evolving into overt enteropathy-type intestinal T- cell lymphoma. Digestion 2000; 62: 60-65
97. Cellier C, Patey N, Mauvieux L et al. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology 1998; 114: 471-481
98. Holtmeier W, Witthöft T, Hennemann A et al. The TCR-α repertoire in human intestine undergoes characteristic changes during fetal to adult development. J Immunol 1997; 158: 5632-5641
99. Holtmeier W. Compartmentalization of γ/δ T cells and their putative role in mucosal immunity. Crit Rev Immunol 2003; 23: 473-488
100. Balk SP, Ebert EC, Blumenthal RL et al. Oligoclonal expansion and CD1 recognition by human intestinal intraepithelial lymphocytes. Science 1991; 253: 1411-1415
101. Gross GG, Schwartz VL, Stevens C et al. Distribution of dominant T cell receptor β chains in human intestinal mucosa. J Exp Med 1994; 180: 1337-1344
102. Weinstein WM, Saunders DR, Tytgat GN et al. Collagenous sprue - An unrecognized type of malabsorption. N Engl J Med 1970; 283: 1297
103. Medlicott SA, Beck PL, Loken S et al. Synchronous collagenous sprue and enteropathy-type T cell lymphoma: variants of the same disease. Can J Gastroenterol 2004; 18: 329-332
104. Freeman HJ. Collagenous sprue associated with an extensive T-cell lymphoma. J Clin Gastroenterol 2003; 36: 144-146
105. Freeman HJ. Collagenous mucosal inflammatory diseases of the gastrointestinal tract. Gastroenterology 2005; 129: 338-350
106. Bossart R, Henry K, Booth CC et al. Subepithelial collagen in intestinal malabsorption. Gut 1975; 16: 18
107. Olesen M, Eriksson S, Bohr J et al. Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients. Gut 2004; 53: 536-541
108. Chande N, McDonald J, Macdonald J et al. Interventions for treating collagenous colitis. Cochrane Database Syst Rev 2005; CD003575
109. Bondemp OK, Hansen JB, Birket-Smith L et al. Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis. Gut 2003; 52: 248-251
110. Biagi F, Lorenzini P, Corazza GR. Literature review on the clinical relationship between ulcerative jejunoileitis, coeliac disease, and enteropathy-associated T-cell. Scand J Gastroenterol 2000; 35: 785-790
111. Elsing C, Placke J, Gross-Weege W. Ulcerative jejunoileitis and enteropathy-associated T-cell lymphoma. Eur J Gastroenterol Hepatol 2005; 17: 1401-1405
112. Swinson CM, Slavin G, Coles EC et al. Coeliac disease and malignancy. Lancet 1983; 1: 111-115
113. Cooper BT, Holmes GK, Cooke WT. Lymphoma risk in coeliac disease of later life. Digestion 1982; 23: 89-92
114. Card TR, West J, Holmes GK. Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study. Aliment Pharmacol Ther 2004; 20: 769-775
115. Carassi C, Fabiani E, Corrao G et al. Risk of non-Hodgkin lymphoma in celiac disease. JAMA 2002; 287: 1413-1419
116. Askling J, Linet M, Gridley G et al. Cancer incidence in a population-based cohort of individuals hospitalized with Celiac disease or dermatitis herpetiformis. Gastroenterology 2002; 123: 1428-1435
117. Loftus CG, Loftus EV, Jr. Cancer risk in celiac disease. Gastroenterology 2002; 123: 1726-1729
118. Smedby KE, Akerman M, Hildebrand H et al. Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Gut 2005; 54: 54-59
119. Hervonen K, Vornanen M, Kautiainen H et al. Lymphoma in patients with dermatitis herpetiformis and their first-degree relatives. Br J Dermatol 2005; 152: 82-86
120. Holmes GKT. Coeliac disease and malignancy. Digestive and Liver Disease 2002; 34: 229-237
121. Howdle PD, Holmes GKT. Small bowel malignancy in coeliac disease. Gut 2004; 53: 470
122. Howdle PD, Jalal PK, Holmes GKT et al. Primary small-bowel malignancy in the UK and its association with coeliac disease. Qjm-An International Journal of Medicine 2003; 96: 345-353
123. Alberg AJ, Samet JM. Epidemiology of lung cancer. Chest 2003; 123: 21S-49S
124. Hausch F, Halttunen T, Maki M et al. Design, synthesis, and evaluation of gluten Peptide analogs as selective inhibitors of human tissue transglutaminase. Chem Biol 2003; 10: 225-231
125. Sollid LM, Khosla C. Future therapeutic options for celiac disease. Nat Clin Pract Gastroenterol Hepatol 2005; 2: 140-147
126. Shan L, Molberg O, Parrot I et al. Structural basis for gluten intolerance in celiac sprue. Science 2002; 297: 2275-2279
127. Cornell HJ, Macrae FA, Melny J et al. Enzyme therapy for management of coeliac disease. Scand J Gastroenterol 2005; 40: 1304-1312
128. Holtmeier W, Caspary WF. Identification of toxic gliadin fragments - new therapeutic options for patients suffering from coeliac disease (nontropical sprue)? Z Gastroenterol 2002; 40: 999-1000
129. Matysiak-Budnik T, Candalh C, Cellier C et al. Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease. Gastroenterology 2005; 129: 786-796
130. Molberg O, Uhlen AK, Jensen T et al. Mapping of gluten T-cell epitopes in the bread wheat ancestors: Implications for celiac disease. Gastroenterology 2005; 128: 393-401
131. Spaenij-Dekking L, Kooy-Winkelaar Y, van Veelen P et al. Natural variation in toxicity of wheat: potential for selection of nontoxic varieties for celiac disease patients. Gastroenterology 2005; 129: 797-806
132. Spaenij-Dekking L, Kooy-Winkelaar Y, Koning F. The Ethiopian cereal tef in celiac disease. N Engl J Med 2005; 353: 1748-1749